Save your place

Sign in to WhoBought

Please try again later.

Vor Biopharma Inc. (VOR) institutional ownership

Latest close $20.05 Jul 21, 2026
Market cap$262M 52-week range SectorHealthcare
Funds holding · Q1 2026
76
reported VOR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
58 buyers · 18 sellers

Vor Biopharma Inc. (VOR) price and institutional activity

Dates

Q1 2026

$0 bought by 58 investors
Tcg Crossover Management, LLCMarshall Wace, LLP +56 more
$0 sold by 18 investors
FMR LLCCitadel Advisors LLC +16 more
Bought Sold Totals per quarter; hover a bar for the names.

Vor Biopharma Inc. (VOR) institutional activity · 76

Investor Type Est. change Change Δ Own Date
Tcg Crossover Management, LLC · New
Change +5.7M Date Q1 2026
Tcg Crossover Management, LLC New· Q1 2026 +5.7M Q1 2026
Marshall Wace, LLP · New
Change +1.2M Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +1.2M Q1 2026
Venrock Adviser, LLC · Added
Change +1.1M Date Q1 2026
Venrock Adviser, LLC Added· Q1 2026 +1.1M Q1 2026
State Street · Added
Change +1.0M Date Q1 2026
State Street Added· Q1 2026 +1.0M Q1 2026
Caligan Partners LP · Added
Change +1000K Date Q1 2026
Caligan Partners LP Added· Q1 2026 +1000K Q1 2026
FMR LLC · Reduced
Change −986K Δ Own −39.1% Date Q1 2026
FMR LLC Reduced· Q1 2026 −986K −39.1% Q1 2026
Vanguard · Added
Change +861K Date Q1 2026
Vanguard Added· Q1 2026 +861K Q1 2026
Rosalind Advisors, Inc. · New
Change +700K Date Q1 2026
Rosalind Advisors, Inc. New· Q1 2026 +700K Q1 2026
Logos Global Management LP · Added
Change +650K Date Q1 2026
Logos Global Management LP Added· Q1 2026 +650K Q1 2026
Boothbay Fund Management, LLC · New
Change +556K Date Q1 2026
Boothbay Fund Management, LLC New· Q1 2026 +556K Q1 2026
Fcpm III Services B.V. · Added
Change +500K Date Q1 2026
Fcpm III Services B.V. Added· Q1 2026 +500K Q1 2026
Braidwell LP · New
Change +467K Date Q1 2026
Braidwell LP New· Q1 2026 +467K Q1 2026
Great Point Partners LLC · Added
Change +380K Date Q1 2026
Great Point Partners LLC Added· Q1 2026 +380K Q1 2026
BlackRock · Added
Change +329K Date Q1 2026
BlackRock Added· Q1 2026 +329K Q1 2026
Clearline Capital LP · New
Change +326K Date Q1 2026
Clearline Capital LP New· Q1 2026 +326K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 76

Famous investor activity in Vor Biopharma Inc. (VOR)

Vor Biopharma Inc. (VOR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ra Capital Management, L.P. · 10% Owner Sell −$4K
Price $19.75 Qty −213 Owned 4.5M ΔOwn 0.0% Trade date Jul 16, 2026 Filed date Jul 21, 2026
Ra Capital Management, L.P. 10% Owner Sell $19.75 −213 −$4K 4.5M 0.0% Jul 16, 2026 Jul 21, 2026
Ra Capital Management, L.P. · 10% Owner 2 operations -$10M
Price $0.00–$5.00 Qty 0 Owned 7.9M Trade date Jul 16, 2026 Filed date Jul 21, 2026
Ra Capital Management, L.P. 10% Owner 2 operations $0.00–$5.00 0 -$10M 7.9M Jul 16, 2026 Jul 21, 2026
Zaccardelli David · Director Grant (A) 43K
Owned 43K Trade date Jul 7, 2026 Filed date Jul 9, 2026
Zaccardelli David Director Grant (A) 43K 43K Jul 7, 2026 Jul 9, 2026
Ra Capital Management, L.P. · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Ra Capital Management, L.P. Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Detheux Michel · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Detheux Michel Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Namouni Fouad · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Namouni Fouad Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Joustra Wouter · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Joustra Wouter Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Kalir Erez · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Kalir Erez Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Cumbo Alexander · Director Grant (A) 56K
Owned 56K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Cumbo Alexander Director Grant (A) 56K 56K Jun 11, 2026 Jun 12, 2026
Beckman Daniella · Director Grant (A) 53K
Owned 53K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Beckman Daniella Director Grant (A) 53K 53K Jun 11, 2026 Jun 12, 2026
Levin Andrew David · Director Grant (A) 57K
Owned 57K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Levin Andrew David Director Grant (A) 57K 57K Jun 11, 2026 Jun 12, 2026
Ra Capital Management, L.P. · Director Sell −$2.6M
Price $15.77 Qty −165K Owned 2.4M Trade date Apr 22, 2026 Filed date Apr 24, 2026
Ra Capital Management, L.P. Director Sell $15.77 −165K −$2.6M 2.4M Apr 22, 2026 Apr 24, 2026
Ra Capital Management, L.P. · Director Sell −$2.7M
Price $15.77 Qty −172K Owned 2.6M Trade date Apr 20, 2026 Filed date Apr 21, 2026
Ra Capital Management, L.P. Director Sell $15.77 −172K −$2.7M 2.6M Apr 20, 2026 Apr 21, 2026
Ra Capital Management, L.P. · Director Sell −$7.5M
Price $16.28 Qty −458K Owned 2.7M Trade date Apr 17, 2026 Filed date Apr 21, 2026
Ra Capital Management, L.P. Director Sell $16.28 −458K −$7.5M 2.7M Apr 17, 2026 Apr 21, 2026
Ra Capital Management, L.P. · Director Sell −$859K
Price $16.01 Qty −54K Owned 3.2M Trade date Apr 15, 2026 Filed date Apr 15, 2026
Ra Capital Management, L.P. Director Sell $16.01 −54K −$859K 3.2M Apr 15, 2026 Apr 15, 2026
15 of 74
15 of 74 Sign in to continue to older insider transactions.

Vor Biopharma Inc. (VOR) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Venrock Healthcare Capital Partners Iii, L.P. 5.1M
% of shares outstanding 9.9% Filing date May 15, 2026
Venrock Healthcare Capital Partners Iii, L.P. 5.1M 9.9% May 15, 2026
Verve Capital Limited 5.0M
% of shares outstanding 9.3% Filing date May 15, 2026
Verve Capital Limited 5.0M 9.3% May 15, 2026
Frazier Life Sciences Public Fund, L.P. 2.3M
% of shares outstanding 5.8% Filing date Dec 19, 2025
Frazier Life Sciences Public Fund, L.P. 2.3M 5.8% Dec 19, 2025
Paradigm Biocapital Advisors LP 1.8M
% of shares outstanding 4.5% Filing date Feb 17, 2026
Paradigm Biocapital Advisors LP 1.8M 4.5% Feb 17, 2026
Great Point Partners, LLC 1.4M
% of shares outstanding 3.3% Filing date Feb 17, 2026
Great Point Partners, LLC 1.4M 3.3% Feb 17, 2026
FMR LLC 1.5M
% of shares outstanding 3.2% Filing date May 6, 2026
FMR LLC 1.5M 3.2% May 6, 2026
Qiming Venture Partners Viii-Hc, L.P. 1.1M
% of shares outstanding 2.0% Filing date May 6, 2026
Qiming Venture Partners Viii-Hc, L.P. 1.1M 2.0% May 6, 2026
7 of 7

Vor Biopharma Inc. (VOR) ownership FAQ

Who owns VOR?

76 reporting institutions disclosed VOR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.